CTC
SRGA

Central Trust Company’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Central Trust Company’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-500
Closed -$92 – 1398
2023
Q2 		$92 Hold
500
– – ﹤0.01% 1225
2023
Q1 		$800 Hold
500
– – ﹤0.01% 1231
2022
Q4 		$995 Buy
500
+4
+0.8% +$10 ﹤0.01% 1197
2022
Q3 		$2K Hold
496
– – ﹤0.01% 1237
2022
Q2 		$2K Hold
496
– – ﹤0.01% 1257
2022
Q1 		$5K Sell
496
-496
-50% -$7.54K ﹤0.01% 1160
2021
Q4 		$21K Buy
+992
New +$26.5K ﹤0.01% 943

Other funds holding SRGA

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
WWP
WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return

Central Trust Company's SRGA Position: Q3 2023 in Review

Central Trust Company sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 500 shares — an estimated $92 sold.

Central Trust Company first reported a position in SRGA in Q4 2021 and held it in 7 quarters. The position peaked at $21K in Q4 2021. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Central Trust Company reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Central Trust Company sold 500 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $92.
  • Central Trust Company first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Central Trust Company's Surgalign Holdings, Inc. Common Stock position peaked at $21K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Central Trust Company's 13F filing for Q3 2023, filed 26 Oct 2023.